OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to ...

Traders poured tens of millions into a triple-leveraged biotech fund in a single day, a move that looks like bold conviction ...

China is proposing new restrictions on foreign acquisitions of critical biopharma technologies, as the country seeks to ...

Huntsville's biotech economy is on the rise. Why it matters: Huntsville's aerospace and defense economy is well-established, ...

Despite an uptick in dealmaking and IPOs, a selective funding market and scientific setbacks are still pushing some biotechs to the brink.

The biotech firm trying to bring extinct species back to life, Colossal Biosciences Inc., will return an egg from the ...

OpenAI has acquired Orchestra Bio, folding its AI agent platform for managing drug programs into the Rosalind life sciences ...

Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry.

Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”), a biotechnology company commercializing and ...

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, presented its first in vivo ...

Jyong Biotech, a Taiwan-based science-driven biotechnology company dedicated to the development and commercialisation of ...